Medical Research (2)


A Review Of Cancer And Aging Specialist, Mikhail Blagosklonny

Mikhail Blagosklonny is a respected scientist. His studies focus on cancer and aging. Presently, he is a professor of oncology at the New York based Roswell Cancer Institute. Throughout his life, Blagosklonny has been interested in science. He enrolled in First Pavlov Medical University where he graduated with his MD in internal medicine. He also holds a PhD in experimental medicine from the St. Petersburg based university. In 2002, Blagosklonny was hired by the New York Medical College to work as an associate professor of medicine. Later, he moved to Ordway Research Institute where he served as a senior scientist. Blagosklonny worked for the institute until 2009 when Roswell Park Cancer Institute recruited him. Follow Mikhail on Google Scholar

Over the years, he has shared his experiences and knowledge to the employees of Roswell Cancer Institute. Mainly, the corporation focuses on cancer research and treatment. Dr. Roswell Park established the institute in 1898. It is regarded as the first medical facility to devote its resources and time to cancer research and treatment in the United States. In upstate New York, Roswell Park is the only institution that holds the National Cancer Institute’s comprehensive cancer center designation. Blagosklonny and other specialists in the institution have been sharing different ideas and potential approaches to fighting cancer. One of these ideas is the tissue specific therapy of cancer.

His research interests center on targeted cancer therapies that shield normal cells from destruction. In addition, Blagosklonny’s research focuses on the essential mechanisms of anti-aging drugs and biogerontology. Mikhail has formulated a hypothesis on the probable role of TOR signaling in cancer and aging. The professor has been a leading supporter of the use of rapamycin, a prominent drug used for cancer treatment. It lengthens the life of cancer patient.

Blagosklonny is the editor in chief of Cell Cycle and Oncotarget, a weekly journal that focuses on oncology. It was founded in 2010. He is also the Cancer therapy and Biology’s editor. Mikhail  Blagosklonny is the founding editor of the American Journal of Pathology, Cancer Research, Cell Death and Differentiation, and the International Journal of Cancer. He has written over 270 papers, which have been published on peer-reviewed journals. Blagosklonny has an h-index of 83. This is because he has more than 25,000 citations. Visit classroomvoices.org to read more about Mikhail.




Leading Treatment Options for COPD Patients at The Lung Institute

Lung disease takes its toll on more than just your health. Most lung diseases and conditions cause you to be out of breath and you become exhausted at a faster rate than those without it. Common illnesses such as the flu, cold, or virus can have dire results in those with severe lung diseases. There are traditional treatment options for these conditions, however, they only treat the symptoms. Traditional treatments will not prevent the progression of the disease either since it does not treat the source of the symptoms.

Stem cell therapy(http://lifestylesafter50.com/adult-stem-cell-therapy-at-the-lung-institute-helps-pulmonary-fibrosis-patient/) has remarkable results. Many choose this procedure because it not only alleviates the symptoms but can stop the disease in its tracks. The Lung Institute is the ideal treatment facility for those suffering from a lung condition and is the leading provider of lung health care. You can find a Lung Institute center in Tampa, Nashville, Scottsdale, Pittsburgh, and Dallas. You will need to be prepared to stay for a few days as the average treatment takes around 3 days regardless of how the stem cells are collected.

To begin the Lung Institute brand of treatment, stem cells must be collected. There are two ways to harvest stem cells. The most common method is through blood venous. This type is typically ideal for patients with mild to moderate cases depending upon disease type. A severe case of extensive damage to this lung tissues will require a higher amount of stem cells. In this case, the stem cells will have to be collected from bone marrow. That can sound scary, but according to experts from Cedars-Sinai, it is actually minimally invasive and is considered to be a very safe procedure.

Once the blood and stem cells have been returned to the bloodstream, the stem cells will be carried to the lungs. Here the stem cells will be caught in pulmonary traps. In this case, it’s exactly what you want to happen. The stem cells will begin replicating the surround healthy cells and replace damaged cells.

To read the testimonials of patients, visit lunginstitute.com.